Spyre Therapeutics (NASDAQ:SYRE) Shares Gap Up Following Analyst Upgrade

Spyre Therapeutics, Inc. (NASDAQ: SYRE - Get Free Report)'s share price gapped up before the market opened on Tuesday after Robert W. Baird raised their price target on the stock from $65.00 to $90.00. The stock had previously closed at $63.27, but opened at $67.68. Robert W. Baird currently has an outperform rating on the stock.